Incorporating PRO data to optimize dose in anti-cancer therapies

Description Exposure-response (E-R) analysis to inform optimal dose in early clinical development of oncology products has traditionally relied on adverse event-based clinician-reported Common Terminology Criteria for Adverse Events. As part of a broader effort to...

Adapting PROs for Research and Clinical Practice Series – Webinar #3

Methods for incorporating CATs (including ePROs) into clinical trials and clinical practice – operational and scientific challenges and solutions Description In this webinar, we intend to provide an overview of considerations for using CAT and ePROs in clinical trials...

Adapting PROs for Research and Clinical Practice Series – Webinar #2

Methods for modifying PRO instruments for clinical practice and clinical research use Description This webinar will describe the steps that the speakers have used in producing symptom and function measure to answer specific questions that emerge in clinical practice...